D A Shepard

445 total citations
11 papers, 328 citations indexed

About

D A Shepard is a scholar working on Cardiology and Cardiovascular Medicine, Infectious Diseases and Molecular Biology. According to data from OpenAlex, D A Shepard has authored 11 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cardiology and Cardiovascular Medicine, 4 papers in Infectious Diseases and 4 papers in Molecular Biology. Recurrent topics in D A Shepard's work include Viral Infections and Immunology Research (5 papers), Respiratory viral infections research (3 papers) and RNA and protein synthesis mechanisms (3 papers). D A Shepard is often cited by papers focused on Viral Infections and Immunology Research (5 papers), Respiratory viral infections research (3 papers) and RNA and protein synthesis mechanisms (3 papers). D A Shepard collaborates with scholars based in United States, Poland and Australia. D A Shepard's co-authors include Roland R. Rueckert, B.A. Heinz, Michael G. Rossmann, Leslie A. Schiff, Thomas J. Smith, M A McKinlay, Frank J. Dutko, John Badger, Pamela J. Skinner and J. C. Sprott and has published in prestigious journals such as Journal of Molecular Biology, Journal of Virology and Journal of Bacteriology.

In The Last Decade

D A Shepard

10 papers receiving 319 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D A Shepard United States	9	143	114	106	106	66	11	328
G. D. DIANA United States	11	369 2.6×	168 1.5×	263 2.5×	132 1.2×	22 0.3×	16	565
Renata Mažuran Croatia	11	28 0.2×	118 1.0×	153 1.4×	83 0.8×	36 0.5×	45	416
D.C. Pevear United States	7	200 1.4×	96 0.8×	227 2.1×	173 1.6×	25 0.4×	9	429
Diane C. Munday United Kingdom	9	33 0.2×	142 1.2×	205 1.9×	135 1.3×	60 0.9×	9	406
Baojing Lu China	9	102 0.7×	105 0.9×	57 0.5×	179 1.7×	24 0.4×	16	340
Peng-Nien Huang Taiwan	10	206 1.4×	206 1.8×	63 0.6×	339 3.2×	18 0.3×	14	550
Pietro Giorgio Spezia Italy	14	77 0.5×	92 0.8×	96 0.9×	257 2.4×	109 1.7×	51	545
Heyrhyoung Lyoo Netherlands	12	250 1.7×	228 2.0×	88 0.8×	183 1.7×	32 0.5×	20	456
M. T. SKOOG United States	6	60 0.4×	135 1.2×	37 0.3×	276 2.6×	24 0.4×	7	396
Peter Buontempo United States	9	159 1.1×	89 0.8×	99 0.9×	204 1.9×	16 0.2×	16	366

Countries citing papers authored by D A Shepard

Since Specialization

Citations

This map shows the geographic impact of D A Shepard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D A Shepard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D A Shepard more than expected).

Fields of papers citing papers by D A Shepard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D A Shepard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D A Shepard. The network helps show where D A Shepard may publish in the future.

Co-authorship network of co-authors of D A Shepard

This figure shows the co-authorship network connecting the top 25 collaborators of D A Shepard. A scholar is included among the top collaborators of D A Shepard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D A Shepard. D A Shepard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Bearz, Alessandra, Jean‐François Martini, Jacek Jassem, et al.. (2023). Efficacy of Lorlatinib in Treatment-Naive Patients With ALK-Positive Advanced NSCLC in Relation to EML4::ALK Variant Type and ALK With or Without TP53 Mutations. Journal of Thoracic Oncology. 18(11). 1581–1593. 26 indexed citations

Shepard, D A. (2013). Between the Lives: Partners in Art. Medical Entomology and Zoology.

Shepard, D A, et al.. (1996). Mutations in the zinc-binding motif of the reovirus capsid protein delta 3 eliminate its ability to associate with capsid protein mu 1. Journal of Virology. 70(3). 2065–2068. 23 indexed citations

Hadfield, Andrea T., Iwona Minor, Marcia J. Kremer, et al.. (1995). Structural Studies on Human Rhinovirus 14 Drug-resistant Compensation Mutants. Journal of Molecular Biology. 253(1). 61–73. 36 indexed citations

Shepard, D A, et al.. (1995). Association of reovirus outer capsid proteins sigma 3 and mu 1 causes a conformational change that renders sigma 3 protease sensitive. Journal of Virology. 69(12). 8180–8184. 27 indexed citations

Mosser, Anne G., D A Shepard, & Roland R. Rueckert. (1994). Use of drug-resistance mutants to identify functional regions in picornavirus capsid proteins. PubMed. 9. 111–119. 5 indexed citations

Shepard, D A, B.A. Heinz, & Roland R. Rueckert. (1993). WIN 52035-2 inhibits both attachment and eclipse of human rhinovirus 14. Journal of Virology. 67(4). 2245–2254. 57 indexed citations

Heinz, B.A., Roland R. Rueckert, D A Shepard, et al.. (1989). Genetic and molecular analyses of spontaneous mutants of human rhinovirus 14 that are resistant to an antiviral compound. Journal of Virology. 63(6). 2476–2485. 101 indexed citations

Shepard, D A, et al.. (1984). Determination of the precise location and orientation of the Escherichia coli dnaE gene. Journal of Bacteriology. 158(2). 455–459. 18 indexed citations

10.

Holly, D. J., S. Prager, D A Shepard, & J. C. Sprott. (1981). Tokamak start-up with electron-cyclotron heating. Nuclear Fusion. 21(11). 1483–1487. 22 indexed citations

11.

Evans, Alfred S., et al.. (1972). ABO blood groups and viral diseases.. PubMed. 45(2). 81–92. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact